Pacira BioSciences, Inc. (PCRX) › Cash & EquivalentsPacira BioSciences, Inc. (PCRX) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2008-12-31: $12.39M2009-12-31: $7.08M2010-12-31: $26.13M2011-12-31: $46.17M2012-12-31: $12.52M2013-12-31: $12.52M2014-12-31: $37.52M2015-12-31: $56.98M2016-12-31: $35.94M2017-12-31: $54.13M2018-12-31: $132.53M2019-12-31: $78.23M2020-12-31: $99.96M2021-12-31: $585.58M2022-12-31: $104.14M2023-12-31: $153.30M2024-12-31: $276.77M2025-12-31: $158.54M$158.54M2008-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$158.54M-42.7%2026-02-26Balance as of period end2024-12-31$276.77M+80.5%2026-02-26Balance as of period end2023-12-31$153.30M+47.2%2025-02-27Balance as of period end2022-12-31$104.14M-82.2%2024-02-29Balance as of period end2021-12-31$585.58M+485.8%2023-02-28Balance as of period end2020-12-31$99.96M+27.8%2022-02-28Balance as of period end2019-12-31$78.23M-41.0%2022-02-28Balance as of period end2018-12-31$132.53M+144.8%2022-02-28Balance as of period end2017-12-31$54.13M+50.6%2021-03-01Balance as of period end2016-12-31$35.94M-36.9%2020-02-21Balance as of period end2015-12-31$56.98M+51.9%2019-02-28Balance as of period end2014-12-31$37.52M+199.8%2018-02-28Balance as of period end2013-12-31$12.52M+0.0%2016-02-25Balance as of period end2012-12-31$12.52M-72.9%2017-03-01Balance as of period end2011-12-31$46.17M+76.7%2015-02-24Balance as of period end2010-12-31$26.13M+269.3%2014-02-25Balance as of period end2009-12-31$7.08M-42.9%2013-03-07Balance as of period end2008-12-31$12.39M—2012-03-27Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)